Chabner Colloquium

 

November 18, 2019
Boston, Massachusetts USA

 

Bruce Chabner

Founded by Dr. Bruce A. Chabner, this annual symposium, presented in joint partnership with the Massachusetts General Hospital Cancer Center, encourages dialogue among experts on topics that bring cancer biology to clinical application. The Chabner Colloquium is an intensive and thoughtful look at the potential for rational, collaborative drug development, tapping into the resources of government, pharmaceutical and biotech companies, and globally statured cancer centers of excellence.

Focusing on new targets and their interventions; strategies for profiling and selection of patients
for targeted drug trials; and biomarkers and animal models to guide clinical development, the entire drug development process is represented. The Chabner Colloquium provides a dialogue that influences trial design, hastens cancer drug development, and, long-term, will rationalize and lend efficiency to the practice of oncology.

2019 Chabner Colloquium

Session 1:
Promising New Targets for Drug Discovery and Development

(Overview) IDH Inhibition in Acute Myeloid Leukemia – Emergence of a New Therapeutic Era
Amir Fathi, MD
MGH/Harvard Medical School

Slides


Clonal Hematopoiesis
Benjamin Ebert, MD, PhD
Dana-Farber Cancer Institute

Slides

(Overview) Epigenetic Reversal of Chemotherapy Resistance in Cancers
Mo Motamedi, PhD
MGH Cancer Center

Session 2:
Junior Faculty Forum

(Overview) ctDNA, a Biomarker of Residual Disease and Tumor Response in Gastrointestinal Cancers
Aparna Raj Parikh, MD
Massachusetts General Hospital

Slides

(Overview) Cross-resistance in Small Cell Lung Cancer
Benjamin Drapkin, MD, PhD
MGH Cancer Center

Slides

(Overview) RET As a Target in Lung Cancer
Jessica J. Lin, MD
Massachusetts General Hospital

Slides

(Overview) Targeting SWI/SNF-Hippo Axis in Squamous Cancers
Srinivas Vinod Saladi, PhD
Massachusetts Eye and Ear Infirmary, MGH,
HMS, Broad Institute

Slides

Luncheon
Keynote Address

(Overview) Innovations in Cell Therapy
Marcela Maus, MD, PhD
MGH Cancer Center

Slides

logos